120 related articles for article (PubMed ID: 25815497)
1. [Efficacy and safety of the WT-2009 chemotherapy protocol in treatment of Wilms' tumor in children].
Guo X; Lin C; Gao J; Zhou CY; Li Q; Zhu YP
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):262-5. PubMed ID: 25815497
[TBL] [Abstract][Full Text] [Related]
2. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract][Full Text] [Related]
3. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report].
Stefanowicz J; Sierota D; Balcerska A; Stoba C
Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594
[TBL] [Abstract][Full Text] [Related]
4. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
5. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.
de Kraker J; Graf N; van Tinteren H; Pein F; Sandstedt B; Godzinski J; Tournade MF;
Lancet; 2004 Oct 2-8; 364(9441):1229-35. PubMed ID: 15464183
[TBL] [Abstract][Full Text] [Related]
6. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumour: a comparison of surgical aspects in patients with or without pre-operative chemotherapy.
Safdar CA; Aslam M; Awan SH; Ahmed I; Badshah S
J Coll Physicians Surg Pak; 2006 Aug; 16(8):521-4. PubMed ID: 16899180
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor--single-center experience with renal surgery.
Seseke F; Zöller G; Ringert RH
Scand J Urol Nephrol; 2004; 38(5):373-7. PubMed ID: 15764247
[TBL] [Abstract][Full Text] [Related]
9. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed Wilms tumour (WT) patients: experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG).
Mavinkurve-Groothuis AM; van den Heuvel-Eibrink MM; Tytgat GA; van Tinteren H; Vujanic G; Pritchard-Jones KL; Howell L; Graf N; Bergeron C; Acha T; Catania S; Spreafico F
Pediatr Blood Cancer; 2015 Apr; 62(4):598-602. PubMed ID: 25546733
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Wilms tumor using carboplatin compared to therapy without carboplatin.
Acipayam C; Sezgin G; Bayram İ; Yılmaz S; Özkan A; Tuncel DA; Tanyeli A; Küpeli S
Pediatr Blood Cancer; 2014 Sep; 61(9):1578-83. PubMed ID: 24729447
[TBL] [Abstract][Full Text] [Related]
12. Wilms' tumor--lessons and outcomes--a 25-year single center UK experience.
Fawkner-Corbett DW; Howell L; Pizer BL; Dominici C; McDowell HP; Losty PD
Pediatr Hematol Oncol; 2014 Aug; 31(5):400-8. PubMed ID: 24933082
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Wilms' tumor in eastern China: 10 years of experience at a single center.
Yao W; Li K; Xiao X; Gao J; Dong K; Xiao X; Lv Z
J Invest Surg; 2012 Jun; 25(3):181-5. PubMed ID: 22583015
[TBL] [Abstract][Full Text] [Related]
14. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study.
Metzger ML; Stewart CF; Freeman BB; Billups CA; Hoffer FA; Wu J; Coppes MJ; Grant R; Chintagumpala M; Mullen EA; Alvarado C; Daw NC; Dome JS
J Clin Oncol; 2007 Jul; 25(21):3130-6. PubMed ID: 17634492
[TBL] [Abstract][Full Text] [Related]
15. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
Aronson DC; Hadley GP
Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01.
Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk JP; Godzinski J; Oldenburger F; Furtwängler R; de Kraker J
Eur J Cancer; 2012 Nov; 48(17):3240-8. PubMed ID: 22795263
[TBL] [Abstract][Full Text] [Related]
18. Bilateral Wilms' tumor: Mansoura multi-centers 15 years experience.
Halim A; Elashry R; Soliman O; Sarhan O
J Oncol Pharm Pract; 2012 Mar; 18(1):115-21. PubMed ID: 22235062
[TBL] [Abstract][Full Text] [Related]
19. [Renal neoplasms in children].
Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
[TBL] [Abstract][Full Text] [Related]
20. [Organ-sparing surgery for nephroblastoma in children].
Ismail-zade RS; Kochubinskiĭ DV; Shimanskiĭ AT; Nazaruk SI; Rutskaia EA; Begin IV; Fedorova AS; Savva NN; Vydanov OI
Vopr Onkol; 2012; 58(4):502-6. PubMed ID: 23607205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
